Table 2. Pharmacokinetic parameters of 19 after intravenous (IV) and oral (PO) administration.
Parametera | 19 |
---|---|
IV dose (mg/kg) | 1 |
T1/2 (h) | 9.69 ± 3.15 |
AUC0–∞ (μg/L*h) | 23318.81 ± 4501.24 |
Cl (L/h/kg) | 0.04 ± 0.01 |
Vdss (L/kg) | 0.35 ± 0.02 |
PO dose (mg/kg) | 10 |
T1/2 (h) | 8.20 ± 1.72 |
AUC0–∞ (μg/L*h) | 53047.73 ± 11030.40 |
Cmax (μg/L) | 5310.50 ± 1910.47 |
Tmax (h) | 1.00 ± 0.87 |
F (%) | 22.75 ± 4.73 |
aCompound was dosed to equal number of male Sprague-Dawley rats in IV and PO administration respectively (n = 3).